SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-23-001864
Filing Date
2023-07-18
Accepted
2023-07-18 08:00:11
Documents
14
Period of Report
2023-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.03: Bankruptcy or Receivership
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c106716_8k-ixbrl.htm   iXBRL 8-K 35558
2 c106716_ex10-1.htm EX-10.1 45735
  Complete submission text file 0000930413-23-001864.txt   236663

Data Files

Seq Description Document Type Size
3 nmtr-20230717.xsd EX-101.SCH 3237
4 nmtr-20230717_def.xml EX-101.DEF 10996
5 nmtr-20230717_lab.xml EX-101.LAB 20892
6 nmtr-20230717_pre.xml EX-101.PRE 11399
8 EXTRACTED XBRL INSTANCE DOCUMENT c106716_8k-ixbrl_htm.xml XML 2546
Mailing Address 4509 CREEDMOOR ROAD SUITE 600 RALEIGH NC 27612
Business Address 4509 CREEDMOOR ROAD SUITE 600 RALEIGH NC 27612 919-275-1933
9 METERS BIOPHARMA, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 273948465 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 231093027
SIC: 2834 Pharmaceutical Preparations